Back to results
CompletedPhase 3

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

NCT00083954

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Research Site

Birmingham, Alabama, United States

+35 additional locations

View on ClinicalTrials.gov
Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression — TrialFind